More evidence for worse COVID-19 outcomes in people with HIV
- PMID: 34655548
- PMCID: PMC8514199
- DOI: 10.1016/S2352-3018(21)00272-1
More evidence for worse COVID-19 outcomes in people with HIV
Conflict of interest statement
MB has received speaking and advising fees and research grants to her Institution from GlaxoSmithKline, Gilead, ViiV, MSD, Cipla, Janssen, Roche, Novavax, Teva, Valneva, Bristol Myers Squibb, Theratech, and Mylan. LW is the Chair of the British HIV Association and has received speaking and advising fees from Gilead, ViiV, MSD, Janssen, Theratech, Mylan, and Cipla.
Comment on
-
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study.Lancet HIV. 2021 Nov;8(11):e701-e710. doi: 10.1016/S2352-3018(21)00240-X. Epub 2021 Oct 13. Lancet HIV. 2021. PMID: 34655549 Free PMC article.
-
Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data.Lancet HIV. 2021 Nov;8(11):e690-e700. doi: 10.1016/S2352-3018(21)00239-3. Epub 2021 Oct 13. Lancet HIV. 2021. PMID: 34655550 Free PMC article.
References
-
- Hoffmann C, Casado JL, Härter G, et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021;22:372–378. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical